Select Medical (SEM)
(Delayed Data from NYSE)
$33.70 USD
+0.56 (1.69%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $33.68 -0.02 (-0.06%) 7:58 PM ET
5-Strong Sell of 5 5
B Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$33.70 USD
+0.56 (1.69%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $33.68 -0.02 (-0.06%) 7:58 PM ET
5-Strong Sell of 5 5
B Value A Growth B Momentum A VGM
Zacks News
Here's Why Select Medical (SEM) Stock is a Strong Buy Now
by Zacks Equity Research
Strategic alliances are bolstering Select Medical's (SEM) growth potential while mitigating the risk factor.
Is Molina Healthcare (MOH) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Low Price-to-Book Stocks to Add Value to Your Portfolio
by Kinjel Shah
The P/B ratio helps to identify low-priced stocks that have high growth prospects. Vishay Intertechnology (VSH), Group 1 Automotive (GPI), Celestica (CLS), Select Medical Holdings Corporation (SEM) and Signet Jewelers Limited (SIG) are some such stocks.
Select Medical (SEM), Inova Health Form JV in Northern Virginia
by Zacks Equity Research
The JV between Select Medical (SEM) and Inova Health System is expected to own and operate a new 32-bed critical illness recovery facility.
Why You Should Retain Humana (HUM) in Your Portfolio Now
by Zacks Equity Research
Humana's (HUM) strategic acquisitions help it boost its footprint and expand the product portfolio.
Will Mednax's (MD) New Name Pediatrix Medical be Beneficial?
by Zacks Equity Research
Mednax's (MD) name change is expected to take effect following the closing bell on Jul 1, 2022.
UnitedHealth (UNH) Unit Eyes $1.5B EMIS Acquisition in UK
by Zacks Equity Research
UnitedHealth's (UNH) Optum business operates in the United Kingdom for two decades and the acquisition is expected to boost its footprint in the country.
Centene (CNC) Raises 2022 Guidance, Ups Share Buyback Fund
by Zacks Equity Research
Currently, Centene (CNC) has $3.6 billion remaining under its share buyback program.
Is Select Medical (SEM) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cigna (CI) Signs $3.5B Accelerated Share Buyback Agreements
by Zacks Equity Research
Cigna (CI) intends to buy back at least $7 billion worth of its stocks this year alone.
5 Stocks Likely to Give Sweet Surprises on Earnings
by Sanghamitra Saha
These top-ranked stocks are likely to beat on the bottom line in their next releases.
Encompass Health (EHC) Forms JV With NCH Healthcare in Naples
by Zacks Equity Research
The NCH Healthcare System's board grants approval to invest in the joint venture with Encompass Health (EHC).
Encompass Health (EHC) Plans to Distribute Enhabit Shares
by Zacks Equity Research
Every Encompass Health (EHC) shareholder will receive one Enhabit common share for every two EHC common shares held.
Should You Hold On to Teladoc Health (TDOC) Stock for Now?
by Zacks Equity Research
Teladoc Health's (TDOC) cash flows will likely gain from the growing number of visits and memberships.
Humana (HUM) Unveils Transition of Units to CenterWell Brand
by Zacks Equity Research
Humana (HUM) announces the rebranding of its pharmacy divisions to the CenterWell brand, reflecting the rapid expansion initiatives to grow the brand and better serve members.
Select Medical (SEM) Inks JV to Serve Venice and Nearby Areas
by Zacks Equity Research
Select Medical (SEM) teams up with Community Health's arm, ShorePoint Health Venice, for jointly operating a hospital dedicated to serve post-acute care needs of patients.
HCA Healthcare's (HCA) Galen College Adds 8th New Facility
by Zacks Equity Research
HCA Healthcare's (HCA) Galen College nursing campus addition comes when the country is suffering from a nursing shortage.
Humana (HUM) to Offer Home Care Model to Virginia's MA Members
by Zacks Equity Research
Humana (HUM) expands the customer reach of its unit's value-based home care model to Virginia, with an aim to offer better in-home care services to the state's Medicare Advantage members.
Here's Why Investors Should Bet on Cigna (CI) Stock Now
by Zacks Equity Research
Cigna (CI) expects 2022 medical customers to grow by a minimum of 725,000, suggesting an upside from the prior projection.
UnitedHealth (UNH) Rewards Shareholders With 13.8% Dividend Hike
by Zacks Equity Research
UnitedHealth's (UNH) strong balance sheet supports its endeavors to return shareholders' funds.
Encompass Health (EHC) Updates 2022 Guidance: Dips 5.4%
by Zacks Equity Research
Encompass Health (EHC) expects to retain its cash dividend routine. However, the amount might decline to reflect the spin-off of the home health and hospice business.
Ensign Group (ENSG) Up 3.7% in 30 Days: More Room to Rally?
by Zacks Equity Research
Ensign Group's (ENSG) rising profits from Skilled Services business are a major positive.
HCA Healthcare's (HCA) Utah Acquisition Faces Fed Roadblocks
by Zacks Equity Research
The trade watchdog expects HCA Healthcare's (HCA) Utah acquisition to induce market concentration and eliminate Steward Health Care as a low-cost competitor.
Zacks Industry Outlook Highlights UnitedHealth Group Anthem, Humana, Centene, and Select Medical
by Zacks Equity Research
UnitedHealth Group, Anthem, Humana, Centene, and Select Medical are part of Zacks Industry Outlook article.
5 HMO Stocks Set to Gain From Membership Growth, M&A Strategy
by Debasmita Chatterjee
Rising membership and a rapidly growing aging U.S. population are likely to drive the performances of the Zacks Medical-HMO industry players. UNH, ANTM, HUM, CNC and SEM are poised to benefit from improved operational efficiencies.